Search

everythinglearnresearchcommunity

for

Search:↓

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Lokivetmab reduced itching in a dog with skin lymphoma.

Overexpression of E2F1 can lead to skin tumors and disrupt hair growth.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Pexidartinib often causes liver issues and fatigue, especially in women.

A lotion with tretinoin, minoxidil, and betamethasone valerate helped treat a woman's skin infection.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

Cetuximab often causes skin problems, but they can be managed without stopping treatment.

Baricitinib may effectively treat oral lichen planus.

Letrozole reduces seizures but not brain damage in mice.

Etretinate was effective for certain skin conditions, but caused side effects like chapped lips, dry mucous membranes, and hair loss.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

Both VEPA and ML-Y1 treatments are not effective enough for elderly non-Hodgkin's lymphoma patients.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Wedelolactone may help treat lung fibrosis by reducing inflammation and lung damage.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Tofacitinib effectively improved hair regrowth and skin condition in a woman with alopecia totalis and lichen planus hypertrophicus.

Oral tofacitinib effectively regrows hair in children with alopecia areata without major side effects.

Docetaxel is effective against various cancers but mainly causes neutropenia.

Erosive pustular dermatosis of the scalp can occur about 17 weeks after starting EGFR inhibitors, and early minocycline may help manage it.